Model Describing Transdermal lontophoretic Delivery of Lidocaine Incorporating Consideration of Cutaneous Microvascular State
- 1 November 1993
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 82 (11) , 1080-1084
- https://doi.org/10.1002/jps.2600821103
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Quantitative Prediction of Transdermal Iontophoretic Delivery of Arbutamine in Humans with the in Vitro Isolated Perfused Porcine Skin FlapJournal of Pharmaceutical Sciences, 1992
- Determination of Lidocaine Concentrations in Skin After Transdermal Iontophoresis: Effects of Vasoactive DrugsPharmaceutical Research, 1992
- Effects of Vasoactive Drugs on Transdermal Lidocaine IontophoresisJournal of Pharmaceutical Sciences, 1991
- A Physiologically Relevant Pharmacokinetic Model of Xenobiotic Percutaneous Absorption Utilizing the Isolated Perfused Porcine Skin FlapJournal of Pharmaceutical Sciences, 1990
- Transdermal Iontophoretic Drug Delivery: Mechanistic Analysis and Application to Polypeptide DeliveryJournal of Pharmaceutical Sciences, 1989
- Iontophoretic delivery of drugs: Fundamentals, developments and biomedical applicationsJournal of Controlled Release, 1988
- Characterization of the Permselective Properties of Excised Human Skin During IontophoresisJournal of Pharmaceutical Sciences, 1987
- New iontophoretic transdermal administration of the beta-blocker metoprololJournal of Controlled Release, 1986
- Comparison Between the Lontophoretic and Passive Transport of Thyrotropin Releasing Hormone Across Excised Nude Mouse SkinJournal of Pharmaceutical Sciences, 1986
- Enhanced percutaneous absorption via iontophoresis I. Evaluation of an in vitro system and transport of model compoundsInternational Journal of Pharmaceutics, 1986